BCL2 and Miyoshi myopathy: Interestingly, we observed that dinaciclib synergizes with BH3 mimetics binding to BCL‐2 or BCL‐XL and increases apoptosis rates in some MM cell lines and plasma cells from MM patients, ex vivo.